David J. Main
2018
In 2018, David J. Main earned a total compensation of $4.2M as Former Chief Executive Officer and President at Aquinox Pharmaceuticals, a 39% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $267,500 |
|---|---|
| Option Awards | $3,413,647 |
| Salary | $535,000 |
| Other | $10,139 |
| Total | $4,226,286 |
Main received $3.4M in option awards, accounting for 81% of the total pay in 2018.
Main also received $267.5K in non-equity incentive plan, $535K in salary and $10.1K in other compensation.
Rankings
In 2018, David J. Main's compensation ranked 2,587th out of 14,244 executives tracked by ExecPay. In other words, Main earned more than 81.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,587 out of 14,244 | 82nd |
Division Manufacturing | 952 out of 5,759 | 84th |
Major group Chemicals And Allied Products | 323 out of 2,122 | 85th |
Industry group Drugs | 262 out of 1,811 | 86th |
Industry Pharmaceutical Preparations | 205 out of 1,385 | 85th |
Source: SEC filing on October 2, 2019.
Main's colleagues
We found two more compensation records of executives who worked with David J. Main at Aquinox Pharmaceuticals in 2018.